SIG
HAE icon

Stonegate Investment Group’s Haemonetics HAE Stock Holding History

Stonegate Investment Group’s Portfolio HAE Stock Details HAE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-3,307
Closed -$247K – 454
2025
Q2 		$247K Buy
+3,307
New +$219K 0.01% 340
2024
Q4 		– Sell
-2,717
Closed -$218K – 412
2024
Q3 		$218K Buy
2,717
+128
+5% +$10.3K 0.01% 335
2024
Q2 		$214K Buy
+2,589
New +$228K 0.01% 329

Other funds holding HAE

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
RRAM
River Road Asset Management Louisville, Kentucky $8.99B AUM 12.83% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Stonegate Investment Group's HAE Position: Q3 2025 in Review

Stonegate Investment Group sold out of Haemonetics (HAE) in Q3 2025, closing a stake of 3,307 shares — an estimated $247K sold.

Stonegate Investment Group first reported a position in HAE in Q2 2024 and held it in 3 quarters. The position peaked at $247K in Q2 2025. 301 funds tracked by Wall St. Rank hold HAE as of Q3 2025.

  • Stonegate Investment Group reported no remaining Haemonetics position as of Q3 2025 after selling out during the quarter.
  • Stonegate Investment Group sold 3,307 Haemonetics shares in Q3 2025, an estimated $247K.
  • Stonegate Investment Group first reported a position in Haemonetics in Q2 2024 and held it in 3 quarters.
  • Stonegate Investment Group's Haemonetics position peaked at $247K in Q2 2025.
  • 301 funds tracked by Wall St. Rank held Haemonetics as of Q3 2025.

Based on Stonegate Investment Group's 13F filing for Q3 2025, filed 3 Nov 2025.